Please assess the completion status of the following clinical trial:

Trial Title: Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing elective laparoscopic colorectal resection at the Queen's Medical Centre, Nottingham~Exclusion Criteria:~* Known allergies to the local anaesthetic~* Any condition which may cause tolerance to opiates (eg chronic opioid use)~* Inability to use a PCA~* Patients less than 45kgs for whom local anaesthetic toxicity may become an issue~* Adults unable to consent for themselves

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- TAP block (Type: EXPERIMENTAL): 40mls of 0.25% L-bupivicaine will be injected into the transversus abdominis plane (TAP) under ultrasound guidance - 20mls on either side of the abdomen.
- Standard care (Type: NO_INTERVENTION): No TAP block is given. Care is otherwise identical to arm 1

Based on this trial design, predict the completion outcome and termination type (if applicable).